Initiator Pharma AS (OSTO:INIT) Net Margin %: 0.00% (As of Mar. 2026)


OSTO:INIT Initiator Pharma AS OSTO:INIT
24 GF Score
Price kr2.72
! 1 Warning Sign
View Full Analysis

What is Initiator Pharma AS Net Margin %?

Initiator Pharma AS OSTO:INIT -1.45% 24 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates OSTO:INIT with a GF Score™ of 24/100. The stock has 1 warning sign investors should review. Among 938 Biotechnology companies, Initiator Pharma AS ranks worse than 106609.7% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Initiator Pharma AS's Net Income for the three months ended in Mar. 2026 was kr-16.65 Mil. Initiator Pharma AS's Revenue for the three months ended in Mar. 2026 was kr0.00 Mil. Therefore, Initiator Pharma AS's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Initiator Pharma AS's Net Margin % or its related term are showing as below:


OSTO:INIT's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.09
* Ranked among companies with meaningful Net Margin % only.

Initiator Pharma AS  (OSTO:INIT) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Initiator Pharma AS Net Margin % Related Terms

Initiator Pharma AS Net Margin % Historical Data

* Premium members only.

The historical data trend for Initiator Pharma AS's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Initiator Pharma AS Net Margin % Chart

Initiator Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Initiator Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OSTO:INIT vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Initiator Pharma AS's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Initiator Pharma AS Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Initiator Pharma AS's Net Margin % distribution charts can be found below:

* The bar in red indicates where Initiator Pharma AS's Net Margin % falls into.


OSTO:INIT
24GF Score
Initiator Pharma AS OSTO:INIT
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Initiator Pharma AS Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Initiator Pharma AS's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-19.942/0
= %

Initiator Pharma AS's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-16.646/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Initiator Pharma AS (OSTO:INIT) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Initiator Pharma AS and its competitors. According to the industry distribution chart, Initiator Pharma AS ranks #999999 out of 938 companies in the Biotechnology industry.
Is Initiator Pharma AS's Net Margin % too high?
Initiator Pharma AS's current Net Margin % is 0.00%. Based on the distribution chart, Initiator Pharma AS ranks #999999 out of 938 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Initiator Pharma AS has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Initiator Pharma AS's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Initiator Pharma AS ranks #999999 out of 938 companies for Net Margin %. This places Initiator Pharma AS in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Initiator Pharma AS and its competitors. Initiator Pharma AS's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Initiator Pharma AS stock overvalued right now?
Initiator Pharma AS (OSTO:INIT) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Initiator Pharma AS's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Initiator Pharma AS (OSTO:INIT), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Initiator Pharma AS Business Description

Address Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Initiator Pharma AS is a Danish clinical-stage life science company developing drugs that target key unmet medical needs within the central and peripheral nervous system. Its pipeline consists of three clinical programs: IP2018 and pudafensine for the treatment of erectile dysfunction of psychogenic and organic origin, respectively.
24GF Score

Get the complete analysis for OSTO:INIT

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.72
Price